Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I saw the insider trading records, CIIX sold all shares last September
I believe an earlier 8K said Roper and Dickman resigned from CIIX to work full time at $MDCL.... However - since that time CIIX is up about 300% while $MDCL is down over 50% so that didn't help poor Medicine Man...
Let's hope financials hit in about 5 or 6 weeks and they are good... That's all that will help this company it seems... GLTA
What do they do? Sale anything? 4 full time ppl?
ChineseInvestors.com (CIIX) has the same corporate leaders as MDCL.
Why doesn't the ChineseInvestor.com website promote MDCL? They share the same executive team? Roper, Dickman, Toreson all on MDCL board...
The company is led by chairman and CEO Warren Wang, COO Brett Roper, CFO Paul Dickman, and Director James Toreson.
https://www.networknewswire.com/chineseinvestors-com-inc-ciix-offers-unique-path-global-chinese-investor-consumer-market/
Thoughts about news postings:
Just wanted to add a few thoughts, I have read quite a few comments about the company not making press releases to promote the company. Many companies do constant press releases with the same news over and over, just rewording them. That is a big sign that there is nothing there and just a way to fluff up their stock price, then later on have the stock price fall to pennies when the reality sets in of their business model and P&L shows the company bleeding.
I believe the MDCL management team is doing the right thing to keep things rolling along without much fanfare until necessary when advancements in the company will send the stock price upward. Just something to keep in mind, the low stock float can make price swings exaggerated and this company is one of the leaders in the industry and profitable.
Thanks for all the feedback, glad to see you all here lurking in the shadows.
Hooparena
Ensuring security and a stable business environment are some concerns companies should have in Pennsylvania, said Marc Harvill, senior consultant at a Denver-based cannabis industry consulting group called Medicine Man Technologies.
"There's going to be a lot of unknowns," said Harvill, who has done consulting work for about 12 Pennsylvania-based startups. "A lot will depend on the patient registry program and the protections for doctors who write the prescriptions."
http://www.ydr.com/story/news/2017/02/01/race-marijuana-permits-york-county/97235692/
Medicine man mentioned in this story.
https://www.newcannabisventures.com/las-vegas-cannabis-cultivation-and-production-facility-for-sale/
Medicine man mentioned in this story.
https://www.newcannabisventures.com/las-vegas-cannabis-cultivation-and-production-facility-for-sale/
Yea, management seems perfectly content to just let the stock drift lower, and they are not promoting their company... It's just not what most MMJ investors want though, so they are leaving... GLTA
Lurking and holding!
Regards
So where did everyone go? Has everyone lost hope? I think the North Star Asset Management purchase shows promise, the only thing that is needed is patience. Thoughts, anyone?
New Purchase: Medicine Man Technologies Inc (MDCL)
North Star Asset Management Inc initiated holdings in Medicine Man Technologies Inc. The purchase prices were between $1.65 and $4.96, with an estimated average price of $2.93. The stock is now traded at around $2.70. The impact to the portfolio due to this purchase was 0.25%. The holdings were 760,000 shares as of 2016-12-31.
Read more: http://www.nasdaq.com/article/north-star-asset-management-inc-buys-hanesbrands-inc-allergan-plc-first-data-corp-sells-cm732077#ixzz4Y0zjztLI
MDCL News: Current Report Filing (8-k) 01/17/2017 08:01:06 AM
MDCL News: Initial Statement of Beneficial Ownership (3) 11/30/2016 02:42:08 PM
MDCL News: Statement of Changes in Beneficial Ownership (4) 11/22/2016 01:13:27 PM
MDCL News: Initial Statement of Beneficial Ownership (3) 11/21/2016 09:55:50 AM
MDCL News: Quarterly Report (10-q) 11/14/2016 04:10:39 PM
Medicine Man Technol (MDCL)
2.44 ? -0.06 (-2.40%)
Volume: 30,682 @ 11:53:48 AM ET
Bid Ask Day's Range
2.45 2.47 2.42 - 2.57
MDCL Detailed Quote
Yes, he likes it a lot, he's talking it down - and will pick up these cheap shares, then go to liking it a lot after financials hit.... Mark this post, lol...
DrugDoc.Brochstein also stopped listing MDCL on the daily dab.MDCL is probably one of the very few legitimate companies in this industry that could have been listed by Brochstein.Right now looks like a golden opportunity to buy.The only problem this industry is facing right now is Sessions BUT,Trump is a business man by trade,not a politician.Think about that.For Trump to ignore the tax revenue this industry CAN create would be one of the biggest mistakes he could make while in office,he has already voiced his opinions on big pharma.I think the industry is about to rally past february 2014.
10-4.... 136
Nice to see You checking this Board out.
MDCL
Oh Canada oh Canada
That's probably why $MDCL has been so weak lately, being bashed down by the so called "expert", so he can load probably, lol...
So Brochstein thinks $MDCL is not a buy huh? This guy has been more wrong on most MMJ stocks than right. I don't see how anyone can consider him an expert, based on the fact of HOW WRONG he has been so many times...
https://www.newcannabisventures.com/why-you-should-continue-to-watch-this-u-s-based-cannabis-stock/
The CEO and COO left the Chinese Investors to devote more time to $MDCL.. Meanwhile the Chinese Investors has risen 200% and $MDCL is down over 40% in the same time period... These folks may know how to run a marijuana business and a consulting business, but return on investment to shareholders is just not happening here... I hope they wise up soon... I'll be here for first quarter financial reporting, but with their lack of promoting the company and stock, and the lack of NEWS when so many other companies in the sector have a soaring stock price, tells me they are not as investor friendly as I had hoped... Oh well, back to waiting...
Also, I owned an Oregon MMJ company that was in the same shape... Never any NEWS at stock languished between .06 and .10... The company finally wised up and started releasing updates... the stock ran up over .50... Wise up $MDCL Management... look around you... MMJ stocks are soaring, but not yours....
Stick sack is a joke and a loser deal. Glad they kicked that one to the curb.
I'll wait for the company.... lol
If they haven't closed those buyouts/mergers by now they never will.
The last 8K shows they expect to close PONO and SUCCESS NUTRIENTS by the end of this quarter... Glad I could help...
Guess you forgot to read the subsequent events section of that last 10Q. Not scare tactics at all. Just the facts. Where are the super 8Ks finalizing all those supposed buyout deals they have?
$MDCL-already-has-the-joint-venture-with-Success-Nutrients-and-PONO- -where-they-are-selling-those-products-to-NEW-CLIENTS. along with collecting fees for the expansion of MMJ after the election in November... I believe I'll wait for real results, vs worrying about undocumented scare material, lol...
And of course, I have a link...
Our other pending acquisition of Pono Publications Ltd. and Success Nutrients, Inc. is in the final stages of due diligence and while no assurances can be provided, we remain optimistic that we will successfully close these transactions during the initial calendar quarter of 2017. It should also be noted that we entered into an ‘Interim Agreement’ with both companies on or about October 20, 2016, as disclosed in an 8K filing on that date that provided for the interaction between the companies pending closing of the acquisition, including various renewals that were not dependent upon the successful completion of this acquisition but substantially benefit all parties.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11784456
One of the new products developed in cooperation with this new partner referred to as Cultivation MAX, a service we will be launching shortly designed to increase the efficiency as well as yields of an existing cultivation operation in states where such operations are lawful wherein we will be able to achieve increased revenues for our client based upon the improvement of cultivation yields. Our clients will not have any obligation to provide additional compensation to us for ongoing operations unless they achieve improved cultivation outcomes. In addition to design and deployment revenue (nutrients included) we will receive for these services fees based upon the margin of improvement yields typical to our industry on a pre-agreed to performance metric reflected in grams per watt, pounds per light, or grams per square foot of flower canopy.
During the three months ended September 30, 2016, we generated revenues of $236,593, including consulting/licensing fees of $233,500, with the balance of fees arising from our participation in cannabis seminars, compared to revenue of $241,140 during the similar period in 2015, a decrease of $4,547. This nominal decrease was primarily attributable to a decrease of $28,047 in revenue derived from seminar fees during the three months ended September 30, 2016, due to our participation is less seminars. However, licensing fees increased by $27,000 during the three months ended September 30, 2016 compared to the similar period in 2015. Based upon executed consulting agreements, we expect to recognize substantial deferred income in future quarters related to existing service agreements that have payment triggers based upon new state legislation in Oregon, California, Pennsylvania and Nevada.
Cost of services, consisting of expense related to delivery of services, was $83,209 during the three months ended September 30, 2016, compared to $35,603 during the comparable period in 2015, an increase of $47,606.
Operating expenses during the three months ended September 30, 2016, were $139,760, including general and administrative expense of $94,099, compared to operating expenses of $155,089 incurred during the three months ended September 30, 2015, including general and administrative expense of $149,443, a decrease of $15,329. Included in these expenses were decreases of $22,548 in travel related expenses due to the completion of our services in Hawaii, and a decrease of $19,107 in professional fees incurred during this period, offset by increased office costs of $14,518 arising from our beginning to pay compensation to our COO.
As a result, we generated net income of $18,752 during the three months ended September 30, 2016 (approximately $0.00 per share), compared to net income of $50,448 during the three months ended September 30, 2015 (approximately ($0.01 per share).
12
While no assurances can be provided, we believe our new cultivation performance metrics as achieved through this new partnership will provide extraordinary value to the industry as a whole for those able to recognize that cost of operations and quality will eventually define who thrives or just survives in this industry.
During the nine months ended September 30, 2016, we generated revenues of $568,388, including consulting/licensing fees of $553,221, with the balance of fees arising from our participation in cannabis seminars, compared to revenue of $623,787 during the similar period in 2015, a decrease of $55,314. This decrease was primarily attributable to a decrease of $15,252 in revenue derived from seminar fees during the nine months ended September 30, 2016 due to our participation is less seminars. Based upon executed consulting agreements, we expect to recognize substantial deferred income in future quarters related to existing service agreements that have payment triggers based upon new state legislation in Oregon, California, Pennsylvania and Nevada.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11687197
Medicine Man (MDCL) Adds Clients & Targets Acquisitions -- CFN Media
Medicine Man Technologies has become a top branding and consulting firm within the rapidly growing legal cannabis and marijuana industry
SEATTLE, WA--(Marketwired - Dec 28, 2016) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing the growth of Medicine Man Technologies Inc. (OTCQB: MDCL) over the recent year and the outlook for the future as more states legalize marijuana.
The cannabis industry is expected to reach $20.6 billion by 2020, according to the market research firm ArcView. With over 20 clients across the United States, Medicine Man Technologies has become a top branding and consulting firm within the rapidly growing industry. Management's recent acquisitions and future pipeline could further drive value in 2017 and beyond as the cannabis industry continues to mature.
By leaning on its experience operating an iconic Colorado dispensary, the company's management team has helped more than 45 clients across 14 states secure licenses, avoid costly start-up mistakes, and consult with an expanding team of licensees and partners as needed.
Medicine Man Technologies, in August, announced a deal to acquire Pono Publications and Success Nutrients to offer enhanced cultivation consulting and extraordinary nutrient lines to its growing client base. With the launch of Cultivation MAX, the company will leverage these technologies to help clients increase the efficiency and yield of existing cultivation operations. The service guarantees a decrease in cost and an increase in yield with fees generated without any upfront cost. Medicine Man is so confident in the system that it doesn't charge fees unless it is as effective as advertised.
During the first three quarters of 2016, the company generated $568,388 in revenue from licensing and consulting fees. Management expects to grow these revenues as existing service agreements hit payment triggers based upon new state legislation in Oregon, California, Pennsylvania and Nevada. Notably, the company also reported a net income of $18,752 during the third quarter, which sets it apart from competitors in an industry where revenues are spotty and net income a rarity.
Organic Growth & Acquisitions
Medicine Man Technologies plans to expand over the coming year through a combination of new clients and strategic acquisitions. New clients continue to add incremental revenue and cash flow, while acquisitions provide opportunities to diversify and upsell to existing clients. With already-profitable operations, investors can directly benefit from the increase and revenue without as much dilution when making acquisitions.
The company is well positioned to organically grow its business as the number of states with legal medical and recreational marijuana continues to increase. In particular, management reported a surge in Pennsylvania business as it works to complete its rules making and application process associated with the passage of SB3 in April 2016. The addition of California to the mix could create significant additional opportunities as the largest revenue market. Medicine Man is currently supporting five Maryland clients with cultivation, processing, and dispensary deployment consulting projects and has also been responding to numerous requests from other Maryland phase one awardees.
In addition, the company continues to build out its brand warehouse concept with a growing pipeline of acquisitions. The Success Nutrients and Pono Publications acquisitions are being finalized, while the acquisition of Capital G (Funk Sack and Odor No) and other earlier stage deals could unlock further value for shareholders. Note that both Pono Publications and Success Nutrients are already profitable and will have generated in excess of $1M in their 1st year of operations (2016).
http://www.otcmarkets.com/stock/MDCL/news/Medicine-Man--MDCL--Adds-Clients--amp--Targets-Acquisitions----CFN-Media?id=147749&b=y
In October alone they have added $1,000,000.00 big ones to there liabilities in convertible debt plus rung up $440,000.00 in additional expenses for a note conversion. Profitable I don't think so!
That's not true... they have a good, profitable business... but they are about as exciting an investment as watching the grass grow, lol... It moves in spurts, about time for a spurt... GLTA
MDCL is below investor radars because it isn't worth anything. Same as its partner CIIX. Both not even worth a slug nickel. Under the guise of SEC reporting filers issuing 8ks for buyouts and mergers that arent worth the paper they are written on.
Yea, I'm thinking about adding one last time down here... $MDCL
Yeah mine too bud! Hang in there our patience will be greatly rewarded here imo!
Regards
Yea, what leaked was my account balance again... Wonder why they haven't finished the PONO acquisition?
This is what we are waiting on.... and also financials...
Our other pending acquisition of Pono Publications Ltd. and Success Nutrients, Inc. is in the final stages of due diligence and while no assurances can be provided, we remain optimistic that we will successfully close these transactions during the initial calendar quarter of 2017. It should also be noted that we entered into an ‘Interim Agreement’ with both companies on or about October 20, 2016, as disclosed in an 8K filing on that date that provided for the interaction between the companies pending closing of the acquisition, including various renewals that were not dependent upon the successful completion of this acquisition but substantially benefit all parties.
So they are selling Success Nutrients and the PONO growing system right now to their clients... Gives one hope, that stellar results will be posted when financials hit..
Probably finally going to file the 8K acquisition for PONO?
Something must have leaked
Wow, this is amazing... look at the bidders now!
Not tons of vol but lots of trades interesting!
Regards
LOL - it's almost like they heard me beoatching, lol... but GLED is still on ask, but he's moving up with the market this time at least...
GLED = Glendale Securities must have a TON of shares to sell... He just sits there all day long with his 100 share ask showing and sells to anyone hitting the ask... Will this ever end? All my other weed stocks have run nicely except for this one, and I think it is the best company of the lot, but GLED NEVER lets it run... sheesh...
Yes they can use those 1.3mil shares for something much more valuable.
The stock is nicely higher today, I think the market agreed that $MDCL didn't need the bag company...
Medicine Man Mentioned:
https://www.theguardian.com/world/2016/may/14/canada-america-cannabis-capital
Maybe it is time to get out of Dodge unless Trump does something Dramatic...Like Legalizing Marijuana Nationwide and he can't do that without the DEA's approval.
JMHO
We didn't need a bag company anyway, lol.... The Pono acquisition is still on.... And... they are looking at another acquisition also.... $MDCL is going to do it right!
Yes, any positive Press Release from the Company could really help here.
I agree, this is a below radar stock for now. What I like about this stock is in fact its below radar. Low volume makes it difficult to trade, but slow accumulation can work. Just holding on. This stock has right ingredients to pop. Be patient.
MJ industry
Name recognition
Acquisitions pending
Low float and Market cap(my favorite)
Although new feds are not fans of legal pot, I highly doubt anything of significance regarding going after states rights by the feds will occur, allowing the continued growth of the industry.
Good luck to all.
I'd say anything below $3 looks good... GLTY
Looking for an entry here $MDCL.
Nah, I won't trade this... just build a position. There are better momo plays in the major markets with more liquidity to trade right now. MJ will be back again, just gotta keep an eye on it meanwhile.
Have fun down in Florida, it's a good time to be headed down that way. I'm stuck in Vegas for now-- not bad at the moment but the weather quickly turns into Hell. NFL playoffs though so I'm having fun at the books at least...
$MDCL
Yes, Medicine Man keeps a very low profile.
The Owners run a tight Ship.
Undiscovered GEM and will be that way for awhile.
Maybe MDCL will pick up in Late Spring..
Like when I come back from My 2 week vacation in Florida.
April 24th, 2017.
Actually, if You have a lot of patience..You can Trade this stock, but I am long and do not care to do that.
Followers
|
128
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
21341
|
Created
|
01/10/16
|
Type
|
Free
|
Moderators StevenRisk Drugdoctor damAcon1 |
Instagram: https://www.instagram.com/schwazze/
Facebook: https://www.facebook.com/Schwazze/
Meet the "Steve Jobs of Cannabis" and Schwazze's Chief Cultivation Officer, Josh Haupt:
https://www.youtube.com/watch?v=s36OIBT4XiQ&t=1s
Star Buds is one of the Most Recognized and Successful Retail Cannabis Operators in North America
Company Projects Pro Forma Revenue for Schwazze and its Two Acquisitions (Mesa Organics and Star Buds) of $95 Million in 2020
Company Expects to Be Cash Flow Positive Beginning in January 2021
Company Anticipates Acquiring Remaining Seven Star Buds Retail Dispensaries in Colorado during the First Quarter 2021
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |